Skip to content

A clinical trial to study the effect of exercises in early stage Parkinsons disease

A randomised controlled trial to study the efficacy of exercises in early stage Parkinsons disease - PARK-EASE trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/014241
Enrollment
30
Registered
2018-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease Health Condition 2: null- PARKINSONS DISEASE (EARLY STAGE)

Interventions

Intervention1: strengthening exercises,aerobic exercise,agility exercises and trunk and active stretching exercises.: strengthening exercise-wall slides,quad strengthening,shoulder blade squeeze,bridg

Sponsors

Raktim Swarnakar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 18 years or older, newly diagnosed Parkinson disease, Hoehn & Yahr stage 1 or 2, on stable pharmacological regimes during the study and for 6 months before entry into the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Improvement in motor symptoms assessed by Unified Parkinson Diseases Rating Scale (UPDRS) section III (motor section)Timepoint: Baseline (at 0 week), at 4th week, at 8th week and at 12 week

Secondary

MeasureTime frame
Improvement in non-motor symptoms assessed by Unified Parkinson Diseases Rating Scale (UPDRS) section I, Improvemt in activities of daily living assessed by UPDRS sections II and VI and Improvement in quality of life assessed by Parkinsons Disease Quality of Life Questionnaire (PDQL Questionnaire)Timepoint: Baseline (at 0 week), at 4th week, at 8th week and at 12 week

Countries

India

Contacts

Public ContactRaktim Swarnakar

AIIMS,New Delhi

wadhwadr@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 8, 2026